Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis.
Pepys MB, Herbert J, Hutchinson WL, Tennent GA, Lachmann HJ, Gallimore JR, Lovat LB, Bartfai T, Alanine A, Hertel C, Hoffmann T, Jakob-Roetne R, Norcross RD, Kemp JA, Yamamura K, Suzuki M, Taylor GW, Murray S, Thompson D, Purvis A, Kolstoe S, Wood SP, Hawkins PN.
Pepys MB, et al. Among authors: hawkins pn.
Nature. 2002 May 16;417(6886):254-9. doi: 10.1038/417254a.
Nature. 2002.
PMID: 12015594